サルコペニア治療の世界市場レポート 2025年

サルコペニア治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.0％で47億2,000万米ドルに成長します。予測期間の成長は、個別化医療、栄養介入、デジタルヘルスプラットフォーム、患者教育とエンパワーメント、世界ヘルスイニシアチブに起因します。予測期間の主な動向には、個別化治療、新規薬剤クラスの出現、デジタルヘルス統合、共同研究イニシアティブ、研究開発が含まれます。

予想される栄養失調の増加は、今後のサルコペニア治療市場の成長を促進すると考えられます。栄養失調は、個人のエネルギーや栄養素の摂取不足、過剰、不均衡を含み、低栄養や過体重、肥満、食事に関連する非感染性疾患を含みます。サルコペニア治療は、筋肉量、筋力、および全体的な栄養状態を高めることを目的とした栄養療法や運動などの介入を通じて、高齢者の栄養不良とサルコペニアの併発状態に対処する上で重要な役割を果たしています。例えば、世界保健機関（WHO）が2023年12月に発表した報告書では、栄養不良が世界の健康上の重要課題であると強調されており、2022年には推定4億6,200万人の低体重者と1億4,900万人の5歳未満児が発育阻害を経験するとされています。その結果、栄養失調の急増がサルコペニア治療市場成長の原動力となっています。

サルコペニア治療市場の主要企業は、治療の選択肢を増やすため、複数の先進的臨床研究の開拓に力を注いでいます。臨床試験は、医療介入の安全性、有効性、および/または結果を評価するために、ヒトを対象として実施される体系的な調査を含みます。例えば、2023年9月、フランスを拠点とするバイオテクノロジー企業Biophytis社は、サルコペニアを対象としたSARA-31フェーズ3試験を開始するための食品医薬品局（FDA）からの認可を公表しました。本試験は、サルコネオス（BIO101）の運動機能障害のリスクを有するサルコペニア患者に対する有効性と安全性を評価することを目的としています。本試験は、サルコネオスの技術的・薬学的治療法における重要な進歩を示すものであり、重症サルコペニア患者に対する有効性と安全性の点で有益な結果をもたらす可能性があります。注目すべきは、FDAの承認を受けたサルコペニアを対象とした初めての第3相試験であるということです。本試験は、サルコペニア、歩行速度低下、握力低下を有する65歳以上の患者約900人を対象とします。主要評価項目は、大移動障害（MMD）リスク、歩行速度、握力、患者報告によるQOLの評価です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界サルコペニア治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のサルコペニア治療市場：成長率分析
• 世界のサルコペニア治療市場の実績：規模と成長, 2019-2024
• 世界のサルコペニア治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界サルコペニア治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のサルコペニア治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プロテインサプリメント
• ビタミンB12サプリメント
• ビタミンDとカルシウムのサプリメント
• その他の治療の種類
• 世界のサルコペニア治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 原発性サルコペニア
• 二次性サルコペニア
• 世界のサルコペニア治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• 経腸
• 世界のサルコペニア治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界のサルコペニア治療市場、タンパク質サプリメントの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホエイプロテイン
• カゼインプロテイン
• 大豆タンパク質
• 植物性タンパク質
• 世界のサルコペニア治療市場ビタミンB12サプリメントの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• シアノコバラミン
• メチルコバラミン
• 世界のサルコペニア治療市場ビタミンDとカルシウムサプリメントの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビタミンD2
• ビタミンD3
• 炭酸カルシウム
• クエン酸カルシウム
• 世界のサルコペニア治療市場、その他の治療タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エクササイズプログラム
• ホルモン補充療法
• その他の栄養介入

第7章 地域別・国別分析

• 世界のサルコペニア治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のサルコペニア治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• サルコペニア治療市場：競合情勢
• サルコペニア治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F-Hoffmann La-Roche Overview, Products and Services, Strategy and Financial Analysis
  • Merck Sharp & Dohme Corp.（Merck & Co.）Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi S.A.
• Abbott Laboratories Inc.
• GlaxoSmithKline plc
• Eli Lilly and Company
• BASF SE
• Nestle Health Science
• Haleon Group of Companies
• Regeneron Pharmaceuticals Inc.
• DSM
• American Way（Amway）Corporation
• Perrigo Company PLC
• Intas Pharmaceuticals Ltd
• Zydus Lifesciences
• Fermenta Biotech Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• サルコペニア治療市場2029：新たな機会を提供する国
• サルコペニア治療市場2029：新たな機会を提供するセグメント
• サルコペニア治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sarcopenia treatment encompasses medical interventions and lifestyle strategies tailored to counteract age-related muscle loss, aiming to preserve or enhance skeletal muscle mass and function. The goal of treatment is to mitigate age-related muscle decline, bolster muscle strength, and improve overall physical function and mobility.

The main types of sarcopenia treatments include protein supplements, vitamin B12 supplements, vitamin D and calcium supplements, and others. Protein supplements, available in forms such as bars, powders, or shakes derived from whey, plant, or meat sources, are utilized for both primary and secondary sarcopenia treatment and can be administered orally, parenterally, or enterally. These supplements are distributed through various channels including hospital pharmacies, retail pharmacies, and online pharmacies.

The sarcopenia treatment market research report is one of a series of new reports from The Business Research Company that provides sarcopenia treatment market statistics, including sarcopenia treatment industry global market size, regional shares, competitors with a sarcopenia treatment market share, detailed sarcopenia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the sarcopenia treatment industry. This sarcopenia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sarcopenia treatment market size has grown strongly in recent years. It will grow from $3.52 billion in 2024 to $3.73 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to aging population, awareness and diagnosis, lifestyle changes, public health initiatives, regulatory approvals.

The sarcopenia treatment market size is expected to see strong growth in the next few years. It will grow to $4.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to personalized medicine, nutritional interventions, digital health platforms, patient education and empowerment, global health initiatives. Major trends in the forecast period include personalized therapies, emergence of novel drug classes, digital health integration, collaborative research initiatives, research and development.

The anticipated increase in malnutrition is poised to drive the growth of the sarcopenia treatment market in the future. Malnutrition encompasses deficiencies, excesses, or imbalances in an individual's intake of energy and nutrients, including both undernutrition and overweight, obesity, and diet-related noncommunicable diseases. Sarcopenia treatment plays a crucial role in addressing the concurrent conditions of malnutrition and sarcopenia in older adults through interventions such as nutritional therapy and exercise, with the aim of enhancing muscle mass, strength, and overall nutritional status. For instance, a report published by the World Health Organization (WHO) in December 2023 highlighted malnutrition as a significant global health challenge, with an estimated 462 million underweight individuals and 149 million children under 5 experiencing stunting in 2022. Consequently, the surge in malnutrition acts as a driving force behind the growth of the sarcopenia treatment market.

Major companies in the sarcopenia treatment market are intensifying their focus on developing multiple advanced clinical studies to enhance treatment options. A clinical study involves a systematic investigation conducted on human subjects to assess the safety, efficacy, and/or outcomes of a medical intervention. For instance, in September 2023, Biophytis, a France-based biotechnology company, disclosed the authorization from the Food and Drug Administration (FDA) to commence the SARA-31 Phase 3 study in sarcopenia. This study aims to assess the efficacy and safety of Sarconeos (BIO101) in treating sarcopenic patients at risk of motor disability. Representing a significant advancement in technological and pharmaceutical treatment modalities, this study offers potential benefits in terms of efficacy and safety for severe sarcopenic patients. Notably, it marks the first-ever Phase 3 study in sarcopenia to receive FDA authorization. The study will involve approximately 900 patients aged over 65 with sarcopenia, low walking speed, and low hand grip strength. The primary endpoints will include the evaluation of the risk of major mobility disability (MMD), walking speed, hand grip strength, and patient-reported quality of life.

In August 2023, Eli Lilly and Company, a pharmaceutical company based in the US, acquired Versanis Bio in a deal valued at $1.925 billion. Through this acquisition, Lilly's portfolio now includes Versanis' key asset, bimagrumab. This drug is currently in a Phase 2b clinical study, being tested both as a standalone treatment and in combination with semaglutide for adults with overweight or obesity. Versanis Bio is a biotechnology company in the US focused on developing treatments for sarcopenia.

Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill

North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sarcopenia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sarcopenia treatment market consists of revenues earned by entities by providing nutritional therapy, combination therapy, and muscle strength. The market value includes the value of related goods sold by the service provider or included within the service offering. The sarcopenia market also includes sales of muscle stimulators, orthopedic braces and supports, joint replacement implants, anabolic agents, and more. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sarcopenia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sarcopenia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sarcopenia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sarcopenia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Protein Supplements; Vitamin B12 Supplements; Vitamin D And Calcium Supplements; Other Treatment Types
• 2) By Type: Primary Sarcopenia; Secondary Sarcopenia
• 3) By Route Of Administration: Oral; Parenteral; Enteral
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• Subsegments:
• 1) By Protein Supplements: Whey Protein; Casein Protein; Soy Protein; Plant-Based Protein
• 2) By Vitamin B12 Supplements: Cyanocobalamin; Methylcobalamin
• 3) By Vitamin D And Calcium Supplements: Vitamin D2; Vitamin D3; Calcium Carbonate; Calcium Citrate
• 4) By Other Treatment Types: Exercise Programs; Hormone Replacement Therapy; Other Nutritional Interventions
• Companies Mentioned: Pfizer Inc.; F-Hoffmann La-Roche; Merck Sharp & Dohme Corp. (Merck & Co.); AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sarcopenia Treatment Market Characteristics

3. Sarcopenia Treatment Market Trends And Strategies

4. Sarcopenia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Sarcopenia Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sarcopenia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sarcopenia Treatment Market Growth Rate Analysis
• 5.4. Global Sarcopenia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sarcopenia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sarcopenia Treatment Total Addressable Market (TAM)

6. Sarcopenia Treatment Market Segmentation

• 6.1. Global Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein Supplements
• Vitamin B12 Supplements
• Vitamin D And Calcium Supplements
• Other Treatment Types
• 6.2. Global Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Sarcopenia
• Secondary Sarcopenia
• 6.3. Global Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Enteral
• 6.4. Global Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.5. Global Sarcopenia Treatment Market, Sub-Segmentation Of Protein Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whey Protein
• Casein Protein
• Soy Protein
• Plant-Based Protein
• 6.6. Global Sarcopenia Treatment Market, Sub-Segmentation Of Vitamin B12 Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cyanocobalamin
• Methylcobalamin
• 6.7. Global Sarcopenia Treatment Market, Sub-Segmentation Of Vitamin D And Calcium Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamin D2
• Vitamin D3
• Calcium Carbonate
• Calcium Citrate
• 6.8. Global Sarcopenia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exercise Programs
• Hormone Replacement Therapy
• Other Nutritional Interventions

7. Sarcopenia Treatment Market Regional And Country Analysis

• 7.1. Global Sarcopenia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sarcopenia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sarcopenia Treatment Market

• 8.1. Asia-Pacific Sarcopenia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sarcopenia Treatment Market

• 9.1. China Sarcopenia Treatment Market Overview
• 9.2. China Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sarcopenia Treatment Market

• 10.1. India Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sarcopenia Treatment Market

• 11.1. Japan Sarcopenia Treatment Market Overview
• 11.2. Japan Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sarcopenia Treatment Market

• 12.1. Australia Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sarcopenia Treatment Market

• 13.1. Indonesia Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sarcopenia Treatment Market

• 14.1. South Korea Sarcopenia Treatment Market Overview
• 14.2. South Korea Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sarcopenia Treatment Market

• 15.1. Western Europe Sarcopenia Treatment Market Overview
• 15.2. Western Europe Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sarcopenia Treatment Market

• 16.1. UK Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sarcopenia Treatment Market

• 17.1. Germany Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sarcopenia Treatment Market

• 18.1. France Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sarcopenia Treatment Market

• 19.1. Italy Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sarcopenia Treatment Market

• 20.1. Spain Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sarcopenia Treatment Market

• 21.1. Eastern Europe Sarcopenia Treatment Market Overview
• 21.2. Eastern Europe Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sarcopenia Treatment Market

• 22.1. Russia Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sarcopenia Treatment Market

• 23.1. North America Sarcopenia Treatment Market Overview
• 23.2. North America Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sarcopenia Treatment Market

• 24.1. USA Sarcopenia Treatment Market Overview
• 24.2. USA Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sarcopenia Treatment Market

• 25.1. Canada Sarcopenia Treatment Market Overview
• 25.2. Canada Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sarcopenia Treatment Market

• 26.1. South America Sarcopenia Treatment Market Overview
• 26.2. South America Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sarcopenia Treatment Market

• 27.1. Brazil Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sarcopenia Treatment Market

• 28.1. Middle East Sarcopenia Treatment Market Overview
• 28.2. Middle East Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sarcopenia Treatment Market

• 29.1. Africa Sarcopenia Treatment Market Overview
• 29.2. Africa Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sarcopenia Treatment Market Competitive Landscape And Company Profiles

• 30.1. Sarcopenia Treatment Market Competitive Landscape
• 30.2. Sarcopenia Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F-Hoffmann La-Roche Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck Sharp & Dohme Corp. (Merck & Co.) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Sarcopenia Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A.
• 31.3. Abbott Laboratories Inc.
• 31.4. GlaxoSmithKline plc
• 31.5. Eli Lilly and Company
• 31.6. BASF SE
• 31.7. Nestle Health Science
• 31.8. Haleon Group of Companies
• 31.9. Regeneron Pharmaceuticals Inc.
• 31.10. DSM
• 31.11. American Way (Amway) Corporation
• 31.12. Perrigo Company PLC
• 31.13. Intas Pharmaceuticals Ltd
• 31.14. Zydus Lifesciences
• 31.15. Fermenta Biotech Limited

32. Global Sarcopenia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sarcopenia Treatment Market

34. Recent Developments In The Sarcopenia Treatment Market

35. Sarcopenia Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Sarcopenia Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sarcopenia Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sarcopenia Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer